Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group.
Interferon therapy lowers the rate of progression to hepatocellular carcinoma in chronic hepatitis C but not significantly in an advanced stage: a retrospective study in 1148 patients. Viral Hepatitis Therapy Study Group.
复制标题
干扰素治疗可降低慢性丙型肝炎进展为肝细胞癌的速度，但在晚期阶段效果并不显着：一项针对 1148 名患者的回顾性研究。
作者：
T. Okanoue;Y. Itoh;M. Minami;S. Sakamoto;K. Yasui;M. Sakamoto;K. Nishioji;Y. Murakami;K. Kashima
